DYKR1 and the DREAM complex are known to contribute to ovarian cancer quiescence, with in vitro evidence showing DYRK1 inhibition causes cancerous ovarian spheroids to lose viability and cells to exit quiescence [162]. This evidence concerns the gene KCNIP3 and ovarian cancer.